Rekah Pharmaceutical Industry Ltd (REKA) — Capital Reinvestment Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Capital Reinvestment Ratio of 0.04x as of June 2026, meaning it reinvests 0% of its operating cash flow (ILA13.82 Million) in capital expenditures (ILA495.00K). Check how tangible is Rekah Pharmaceutical Industry Ltd's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Rekah Pharmaceutical Industry Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Rekah Pharmaceutical Industry Ltd's Capital Reinvestment Ratio across 21 annual periods. For the full cash flow conversion analysis, see REKA cash flow conversion.
Annual Capital Reinvestment Ratio for Rekah Pharmaceutical Industry Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Rekah Pharmaceutical Industry Ltd from 2002 to 2025. See REKA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.54x | ILA12.95 Million | ILA7.03 Million | ▲ +65.5% |
| 2024 | 0.33x | ILA26.54 Million | ILA8.70 Million | ▼ -19.1% |
| 2023 | 0.41x | ILA28.35 Million | ILA11.49 Million | ▲ +111.3% |
| 2022 | 0.19x | ILA39.00 Million | ILA7.48 Million | ▼ -71.0% |
| 2021 | 0.66x | ILA21.17 Million | ILA13.99 Million | ▼ -60.4% |
| 2020 | 1.67x | ILA11.28 Million | ILA18.84 Million | ▲ +24.7% |
| 2019 | 1.34x | ILA33.91 Million | ILA45.40 Million | ▲ +52.5% |
| 2018 | 0.88x | ILA17.28 Million | ILA15.18 Million | ▲ +26.8% |
| 2017 | 0.69x | ILA23.80 Million | ILA16.48 Million | ▲ +17.6% |
| 2016 | 0.59x | ILA22.82 Million | ILA13.44 Million | ▼ -74.0% |
| 2015 | 2.26x | ILA5.81 Million | ILA13.15 Million | ▼ -84.4% |
| 2014 | 14.49x | ILA1.33 Million | ILA19.27 Million | ▲ +3767.8% |
| 2013 | 0.37x | ILA11.71 Million | ILA4.38 Million | ▼ -45.9% |
| 2012 | 0.69x | ILA14.18 Million | ILA9.82 Million | ▼ -40.8% |
| 2010 | 1.17x | ILA6.73 Million | ILA7.87 Million | ▲ +226.1% |
| 2009 | 0.36x | ILA26.03 Million | ILA9.33 Million | ▼ -78.0% |
| 2008 | 1.63x | ILA6.57 Million | ILA10.73 Million | ▲ +285.0% |
| 2007 | 0.42x | ILA12.45 Million | ILA5.28 Million | ▼ -74.4% |
| 2005 | 1.66x | ILA4.27 Million | ILA7.09 Million | ▲ +530.7% |
| 2004 | 0.26x | ILA17.87 Million | ILA4.70 Million | ▲ +20.9% |
| 2002 | 0.22x | ILA11.21 Million | ILA2.44 Million | — |